Type 1 diabetes (T1D) self-management can be challenging, involving multiple daily injections of insulin (MDI) or continuous subcutaneous insulin infusion (CSII), guided by self-monitoring of glucose [6]. The gene discussed is INS; the disease is type 1 diabetes mellitus.